Brooks Laboratories
BROOKS · Pharma > Pharmaceuticals & Drugs · Chairman: Atul Ranchal · MD: Rajesh Mahajan · Listing date: Sept. 5, 2011 · Employees: 389 · Mumbai · http://www.brookslabs.net

Stock Price vs Company Growth
1d
3.3%
1w
18.3%
1m
2.3%
3m
34.4%
6m
47.6%
1y
30.7%
5y
40.0%
10y
16.3%
all
8.6%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 150 3.3%
94.2
162
Company Overview

Sales
81.7 Cr
Growth: 12.5%
Profit after Tax
-17.5 Cr
Growth: -10.5%
Micro Cap
393 Cr
P/S: 4.7x
Industry P/S: 3.3x
Fundamentals

Sales (Cr) ₹ 81.7
Growth 12.5%
EBITDA 4.3%
P/S 4.7x
Dividend 0.0%
P/E -21.2x
Book Value ₹ 27.8
PEG Ratio -1.7x
ROE -22.6%
P/B 5.3x
Shareholding Pattern

Institutions
Guttikonda Vara Lakshmi
2.56 %
Llp
0.09 %
Promoters
Atul Ranchal
25.35 %
Rajesh Mahajan
20.7 %
Aryan Mahajan
4.6 %
Erwin Mahajan
4.6 %
Rajni Ranchal
3.49 %
Others
Increase    Decrease    No change
Company Profile Detailed

The Company was originally incorporated as Brooks Laboratories Limited on January 23, 2002. Company was initially promoted for manufacturing of latest molecules in Injectables, tablets and dry syrups for the domestic customers. The Company set up a facility for manufacturing Tablets, Dry Syrup and Injectables, which was supported by a research and development centre at Baddi, Himachal Pradesh.
Investors (44)
Followers (1)